Tien Liang BioTech Co., Ltd. (TPEX:4127)

Market Cap	1.53B
Revenue (ttm)	467.02M
Net Income (ttm)	-3.25M
Shares Out	45.76M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	573,405
Average Volume	63,845
Open	33.70
Previous Close	33.50
Day's Range	33.55 - 36.85
52-Week Range	29.00 - 41.00
Beta	0.38
RSI	70.21
Earnings Date	Mar 13, 2026

About Tien Liang BioTech

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, lower back pain and sore feet, dizziness and blurred vision, thirst, dry tongue and sore throat, and heel pain, as well as rheumatic pain, joint pain, generalized pain, wind-cold-dampness arthralgia, gout, neuralgia, bedwetting, hemorrhoids, and constipation indications; resolving and cough-relieving powder for colds, coughs, bronchitis, cough suppressants, and expect...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1971
• Employees: 61
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4127

Financial Performance

In 2024, Tien Liang BioTech's revenue was 385.21 million, a decrease of -16.26% compared to the previous year's 459.99 million. Earnings were 11.70 million, a decrease of -34.04%.